• Abstract and Figures
• Public Full-text

Follow us on: RNI No. APENG/2018/764698 @TheDailyPioneer facebook.com/dailypioneer Established 1864 Published From ANALYSIS 7 MONEY 8 SPORTS 11 VIJAYAWADA DELHI LUCKNOW CRIME AND FUEL SALES SLUMP 50% IN APRIL; SEAM & SWING TOP BHOPAL RAIPUR CHANDIGARH PUNISHMENT PETROL DOWN 64%, DIESEL 61% PRIORITIES FOR SHAMI BHUBANESWAR RANCHI DEHRADUN HYDERABAD *Late City Vol. 2 Issue 165 VIJAYAWADA, SATURDAY APRIL 18, 2020; PAGES 12 `3 *Air Surcharge Extra if Applicable UPPI’S NEXT MOUNTED ON RS 80 CRORE { Page 12 } www.dailypioneer.com GERMANY SAYS ITS VIRUS ROCHE PHARMA EYES COVID-19 SOUTH KOREA SEES RISE IN PAPER TOWELS MORE EFFECTIVE THAN OUTBREAK IS ‘MANAGEABLE’ ANTIBODY TEST LAUNCH IN MAY SECOND-TIME VIRUS DIAGNOSES HAND DRYERS AT REMOVING VIRUSES ermany's health minister says the coronavirus outbreak in the country has wiss pharmaceutical giant Roche said Friday it had developed an antibody outh Korea says it's continuing to see a rise in patients who test positive for sing paper towels to dry hands is substantially more effective than jet Gbecome “manageable,” with new data showing the rate of new infections Stest that it hopes to roll out in May to detect people previously infected Sthe coronavirus for a second time after being diagnosed as recovered. Udryers for removing viruses, including the novel coronavirus that causes has slowed significantly. Jens Spahn told reporters in Berlin on Friday that the with COVID-19, even those who displayed no symptoms.Roche said in a However, the risk of transmissions from such cases so far appears to be low. COVID-19, according to a study. Hand drying is important to minimise the increase in COVID-19 cases isn't exponential anymore, but linear. Figures statement that it had developed the Elecsys Anti-SARS-CoV-2 immunoassay, Jeong Eun-kyeong, director of the country's Centers for Disease Control and spread of dangerous microbes since failure to remove them increases transfer released by the Robert Koch Institute, Germany's disease control which using a blood sample can detect antibodies to determine the Prevention, said Friday at least 163 people have tested positive again after their to environmental surfaces and increases the opportunities center, show that the number of people infected by every person body's immune reaction to the novel coronavirus that causes initial release from hospitals, accounting for more than 2% of the for transmission and spread, the researchers said. The with COVID-19 has fallen to 0.7, from over 1 just a few days COVID-19. Research teams around the world have been country's 7,829 recoveries. She says the patients on average researchers, including those from University of Leeds in ago. German Chancellor Angela Merkel said this week that this racing to develop such so-called serology tests for the were 13.5 days removed from their release when they tested the UK, investigated whether there are differences in so-called reproduction rate was a key indicator the virus, known as SARS-CoV-2, that has sparked the positive again, although the longest gap was 35 days. Jeong extent of virus transmission, according to hand drying government would take into account when deciding global pandemic with more than 2.1 million says none of the patients were in serious condition although method, beyond the washroom to the hospital whether to relax the lockdown. infections and over 141,000 deaths. 61 of them were exhibiting mild symptoms. environment. A GLIMMER OF HOPE Covid-19 has no doubt shaken the world and turned it upside down, but there is a glimmer of hope from at least three major factors, after nearly six months of uncertainty about the mutating virus strain. Firstly, Remdesivir, an antiviral treatment previously tested in humans for Ebola, seems to have cured about 70% of Covid-19 patients. Secondly, it is now taking longer for Covid-19 cases to double in India (6.2 days)Thirdly, Oppn to coron- avirus victim's Indian scientists are testing Mw, a multi-purpose vaccine that has proved effective against leprosy and boosts funeral blot on immunity in hosts, to see if it can help tackle Covid-19 society: Naidu Gilead’s drug Remdesivir shows Doubling rate of 4 promise against COVID-19 cases in India reduced PNS n NEW YORK Remdesivir by Gilead Sciences is one of several NEW DELHI: The Union Health Ministry said on Friday the rate at which drugs being fast-tracked into trials by the World the number of coronavirus cases in the country was becoming double A potential drug from phar- in the last one week was 6.2 days, as against three days before the maceutical major Gilead Health Organization, comparing potential nationwide lockdown was imposed. At a daily Sciences has shown tremen- treatments in hospitalised COVID-19 patients in a media briefing about updates on COVID-19 dous promise in an ongoing situation, Joint Secretary in the Health Ministry India clinical trial at the University dozen countries, including Canada Lav Agarwal claimed that India of Chicago Medical Center has been doing better than where 36 of 53 severe COVID- been discharged, which is Sciences is one of several drugs many other countries on the testing vaccine 19 patients who were treated great. We've only had two being fast-tracked into trials by outcome ratio, which is the with anti-viral medicine patients perish," Kathleen the World Health number of recoveries from NEW DELHI Indian scientists are testing a remdesivir have shown clini- Mullane, the University of Organization, comparing coronavirus infection multi-purpose vaccine that has proved effective cal improvement. Chicago infectious disease spe- potential treatments in hospi- versus the number of against leprosy and boosts immunity in hosts to see if According to a report in The cialist overseeing the remde- talised COVID-19 patients in deaths. "If 80 per cent it can help tackle the coronavirus, the chief of country's STAT, the researchers saw sivir studies for the hospital, a dozen countries, including of the patients in India largest public-funded research institution told NDTV on RBI steps will rapid recoveries in fever and was quoted as saying. Canada. are recovering and in Friday."With the approval of the DCGI (Drug Controller General help protect respiratory symptoms, with Gilead said in a statement: Treatment with Gilead 20 per cent cases of India), we have begun tests on the MW vaccine that has been nearly all patients discharged "What we can say at this stage Sciences's experimental drug deaths are being successfully used against leprosy," Dr Shekhar Mande, Director livelihoods of in less than a week. is that we look forward to data remdesivir led to clinical reported, then by that General of the Council of Scientific and Industrial Research (CSIR), people: Nadda Gilead's shares jumped from ongoing studies becom- improvement in 68 per cent of standard India has said. "Making a vaccine is a lengthy process. The research is going more than 15 per cent in ing available". 53 patients hospitalised with been doing a little on. We are working on a vaccine that improves the immunity in after-hours trading and Dow Gilead's severe Covid-19 severe complications of better than many other hosts. We are awaiting two more approvals. Once we have those, we futures surged more than 800 study includes 2,400 partici- COVID-19, another study said nations on the will start trials. We will know the results within the next six weeks," Dr points on Thursday following pants from 152 different clin- this week. The drug was pro- outcome ratio," he Mande said. The World Health Organisation has said a specific vac- 5 the report. ical trial sites all over the vided on an individual com- said. cine for the novel coronavirus that has triggered the ongoing COVID- "The best news is that most world. passionate use basis. 3 19 pandemic could take at least 12 months or longer. of our patients have already Remdesivir by Gilead 3 3 38 new virus One lakh South Korea-made People hide Govt fudging Covid cases take symptoms on test figures: Naidu tally to 572 rapid test kits reach State stigma fears PNS n VIJAYAWADA PNS n VISAKHAPATNAM PNS n VIJAYAWADA ence with party leaders, Naidu PNS n VIJAYAWADA said that the CM’s dashboard The number of Covid-19 cases Fear of quarantine and also Telugu Desam Party supremo claimed that 11,613 tests have in the state shot up to 572 with As part of Coronavirus pre- social stigma are believed to N Chandrababu Naidu on been carried out across the 38 more people testing positive ventive measures, the Andhra be the main reasons holding ‘RBI measures to Friday termed the official state on Wednesday but the for the virus in the last 24 Pradesh government has pur- people back from visiting Covid-19 health bulletins figure was increased to 20,235 hours, according to the health chased one lakh rapid Covid- doctors or getting tested boost liquidity, released by the state govern- by Thursday. “It claimed that bulletin released by the state 19 testing kits, which can despite showing symptoms of incentivise ment daily as 'bogus and full 8,622 tests have been carried government on Friday. generate results in just ten Covid-19. A senior health of false claims’. He said that out in just 12 hours while the Among the new 38 cases, minutes. These kits were official, requesting anonymi- banks to lend this was because of the YSRC Health Secretary said 16,555 Kurnool reported 13, SPS brought to the State on a spe- ty, said “The government is more’ regime's plan to send false tests were carried out.

Load more

  12

Copy Link